Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Short/Acting Psychedelics
Recent news which mentions Short/Acting Psychedelics
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
Tickers
CYBN
DMTTF
Tags
Psychedelics
Benzinga
CYBN
From
Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
August 28, 2023
Tickers
CYBN
DMTTF
Tags
Psychedelics
Benzinga
DMT Clinical Trial
From
Benzinga
Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change
July 05, 2023
Tickers
DMTTF
Tags
Benzinga
Psychedelics
Psychedelic/Assisted Therapies
From
Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
Tags
major depressive disorder
Markets
Market News
From
Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
February 15, 2023
Tickers
DMTTF
Tags
Next/Generation Psychedelics
Global
Cannabis
From
Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
Tags
Penny Stocks
News
DMTTF
From
Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
Tags
SPL026
Benzinga
Psychedelics
From
Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
Tickers
DMT
DMTTF
Tags
Legal
Short/Acting Psychedelics
MHRA
From
Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
October 19, 2022
Tickers
DMTTF
Tags
Psychedelics
Benzinga
Biotech
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.